DOI QR코드

DOI QR Code

Anti-inflammatory and Anti-Pruritonic Effects of WSY-1075 composited with Medicinal Plants on the Activated Rat Peritoneal Mast cells and Mouse Pruritus

활성화된 렛트 비만세포와 마우스 소양증에 대한 한약재로 조성된 WSY-1075의 항염증 및 항소양 효과

  • Hwang, Sung Yeoun (Department of Oriental Medical Prescription, Woosuk University) ;
  • Lee, Seung Ho (Department of Oriental Medical Prescription, Woosuk University) ;
  • Lee, Chia Wei (Department of Oriental Medical Prescription, Woosuk University) ;
  • Kim, Jang Ho (Honam institute for Regional Program) ;
  • Jang, Seon Il (Department of Healthcare & Science, Jeonju University) ;
  • Kim, An Na (Department of Oriental Medical Prescription, Woosuk University) ;
  • Kim, Hong Jun (Department of Oriental Medical Prescription, Woosuk University)
  • 황성연 (우석대학교 한의과대학 방제학교실) ;
  • 이승호 (우석대학교 한의과대학 방제학교실) ;
  • 이가위 (우석대학교 한의과대학 방제학교실) ;
  • 김장호 (호남지역사업평가원) ;
  • 장선일 (전주대학교 보건관리학과) ;
  • 김안나 (우석대학교 한의과대학 방제학교실) ;
  • 김홍준 (우석대학교 한의과대학 방제학교실)
  • Received : 2013.06.20
  • Accepted : 2013.07.18
  • Published : 2013.07.30

Abstract

Objectives : This study was to evaluate the anti-inflammatory and anti-pruritic effects of WSY-1075 composited with Corni Fructus, Angelica gigantis Radix, Lycii Fructus, Ginseng Radix, Cervi parvum Cornu and Cinnamomi Cortex in rat peritoneal mast cells (RPMCs) and scratching mouse model. Methods : WSY-1075 was prepared by extracting with 30% ethanol. In the present study, we investigated the effect of WSY-1075 on the production of tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), interleukin-$1{\beta}$ (IL-$1{\beta}$) and histamine in rat peritoneal mast cells (RPMCs) activated with phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187, and on the scratching behavior in mice treated with pruriogens. Results : WSY-1075 was not cytotoxic effect in used all concentration. PMA plus A23187 treatment significantly increased TNF-${\alpha}$, IL-$1{\beta}$ and IL-6 production compared with media control in RPMCs. However, TNF-${\alpha}$, $IL1{\beta}$ and IL-6 production increased by PMA plus A23187 treatment were significantly inhibited by WSY-1075 (200 ${\mu}g/mL$ and 400 ${\mu}g/mL$). WSY-1075 also inhibited the histamine release from RPMCs stimulated by compound 48/80, which promotes histamine release. Moreover, WSY-1075 administration had an inhibitory effects on the scratching behavior induced by pruritogen (compound 48/80, histamine, serotonin and substence P) in ICR mice. Conclusion : These results suggest that WSY-1075 administration (200 mg/kg or 400 mg/kg) has the anti-inflammatory and anti-pruritic effects on the activated rat peritoneal mast cell and mouse pruritus. WSY-1075 has a potential use as a composition of medicinal plants for treatment against inflammation- and pruritus-related disease.

Keywords

References

  1. Wang Gu. Sijaebaekilseonbang. Shanghai : Publishing house of Shanghai University of Traditional Chinese Medicine. 1991 : 280.
  2. Heo Joon(writing), translating department of orintal medical books(translator). New translation printed side by side with original Donguibogam. Seoul : Beopinmoonhwasa. 2007 : 1251.
  3. Nakae S, Suto H, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc Natl Acad Sci USA. 2005 ; 102 : 6467-72. https://doi.org/10.1073/pnas.0501912102
  4. Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Therianou A, Kalogeromitros D, Theoharides TC. Mast cells in allergic and inflammatory diseases. Curr Pharm Des. 2012 ; 18 : 2261-77. https://doi.org/10.2174/138161212800165997
  5. Leung DY. Immunologic basis of chronic allergic diseases: clinical messages from the laboratory bench. Pediatr Res. 1997 ; 42 : 559-68. https://doi.org/10.1203/00006450-199711000-00001
  6. Galli SJ. New concepts about the mast cell. N Engl J Med. 1993 ; 328 : 257-65. https://doi.org/10.1056/NEJM199301283280408
  7. Mekori YA. Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000 ; 173 : 131-40. https://doi.org/10.1034/j.1600-065X.2000.917305.x
  8. Aoki R, Kawamura T, Goshima F, Ogawa Y, Nakae S, Nakao A, Moriishi K, Nishiyama Y, Shimada S. Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-$\alpha$ and IL-6 Production. J Invest Dermatol. 2013 : in press.
  9. Choi IY, Kim SJ, Kim MC, Kim HL, Shin HJ, Kang TH, Jeong HJ, Shim JS, Kim JH, Yang DC, Hong SH, Kim HM, Um JY. Inhibitory effects of the transgenic Panax ginsengs on phorbol ester plus A23187-induced IL-6 production and cyclooxygenase-2 via suppression of NF-$\kappa{B}$ and MAPKs in HMC-1. Immunopharmacol Immunotoxicol. 2011 ; 33 : 205-10. https://doi.org/10.3109/08923973.2010.496459
  10. Takai T, Ikeda S. Barrier dysfunction caused by environmental proteases in the pathogenesis of allergic diseases. Allergol Int. 2011 ; 60 : 25-35. https://doi.org/10.2332/allergolint.10-RAI-0273
  11. Spergel JM. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am. 2010 ; 30 : 269-80. https://doi.org/10.1016/j.iac.2010.06.003
  12. Kay AB. Overview of allergy and allergic diseases: with a view to the future. Br Med Bull. 2000 ; 56 : 843-64. https://doi.org/10.1258/0007142001903481
  13. Metz M, Grundmann S, Stander S. Pruritus: an overview of current concepts. Vet Dermatol. 2011 ; 22 : 121-31. https://doi.org/10.1111/j.1365-3164.2010.00945.x
  14. Pfaar O, Raap U, Holz M, Hormann K, Klimek L. Pathophysiology of itching and sneezing in allergic rhinitis. Swiss Med Wkly. 2009 ; 139 : 35-40.
  15. Lasic D, Cvitanovic MZ, Uglesic B, Visic V, Hlevnjak I. Exanthema medicamentosum as a side effect of promazine. Psychiatr Danub. 2011 ; 23 : 194-71.
  16. Martynova MG, Bystrova OA, Moiseeva OM, Evdonin AL, Kondratov KA, Medvedeva ND. The presence of ANP in rat peritoneal mast cells. Cell Res. 2005 ; 15 : 811-6. https://doi.org/10.1038/sj.cr.7290350
  17. Mihara K, Kuratani K, Matsui T, Nakamura M, Yokota K. Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermato. 2004 ; 151 : 335–45. https://doi.org/10.1111/j.1365-2133.2004.06036.x
  18. Chang YH. (The)experimental study on the effect of Kongjindan on the Kangjeongboki action in rats. Daegu Haany University. 1989.
  19. Jung HC, Jang HJ, Sung WY, Lee SH, Son JH, Han SH. A study of Gongjin-dan in patients with mild Dementia of Alzheimer type. J Orient Neuropsychiatry. 2004 ; 15(2) : 141-8.
  20. Hwang SM, Chung DK. The Effects of KongJin-Dan(KJD) on the Alzheimer's Disease Model Induced by CT105. J Orien Neuropsychiatry. 2004 ; 15(2) : 103-18.
  21. Choi KH, Park CS. An analysis of the Gongjindan's ingredients and its efficacy on anti-oxidation. Korea J Herbology. 2007 ; 22(2) : 51-63.
  22. Kim HJ, Hwang SY, Mok JY, Hwang BS, Jeong SI, Jang SI. Gagam-Gongjin-dan Extract Attenuates Immune Responses to Ovalbuminin Balb/c Mice. Kor J Herbology. 2009 ; 24(4) : 127-35.
  23. Kim HJ, Mok JY, Park KH, Jeong SI, Hwang BS, Hwang SY, Cho JK, Jang SI. Hepatoprotective Effect of Gagam-GongJin-dan extract against Acetaminophen-Induced Liver Injury in Mice. Kor J Herbology. 2010 ; 25(3) : 149-57.
  24. Kim OK. Antidiabetic and Antioxidative Effect of Lycii fructus in Streptozotocin-Induced Diabetic Rats. Kor J Pharmacogn. 2009 ; 40(2) : 128-36.
  25. Cho YJ, Chun SS, Cha WS, Park JH, Lee KH, Kim JH, Kwon HJ, Yoon SO. Antioxidative and Antihypertensive Effects of Lycii fructus Extracts. J Kor Soc Food Sci Nutr. 2005 ; 34(9) : 1308-13. https://doi.org/10.3746/jkfn.2005.34.9.1308
  26. Ju YS. JeungBo-Ungokherbology. Jeonju : Woosuk Press. 2013 : (上)779-82, (下)1194-204, 1346-49.
  27. Park YC, Lim JD, Kim JB, Lee SD. Review of Red Ginseng in terms of Mechanisms for Pharmacodynamics and Toxicity. J Kor Orient med. 2012 ; 33(3) : 200-30.
  28. Oh YC, Kang OH, Kim SB, Mun SH, Park CB, Kim YG, Kim YI, Lee YS, Han SH, Keum JH, Shin DW, Ma JY, Kwon DY. Anti-inflammatory effect of sinomenine by inhibition of pro-inflammatory mediators in PMA plus A23187-stimulated HMC-1 Cells. Eur Rev Med Pharmacol Sci. 2012 ; 16 : 1184-91.
  29. Kim SJ, Jeong HJ, Yi BJ, Kang TH, An NH, Lee EH, Yang DC, Kim HM, Hong SH, Um JY. Transgenic Panax ginseng inhibits the production of TNF-alpha, IL-6, and IL-8 as well as COX-2 expression in human mast cells. Am J Chin Med. 2007 ; 35 : 329-39. https://doi.org/10.1142/S0192415X07004850
  30. Ganeshan K, Johnston LK, Bryce PJ. TGF-$\beta1$ Limits the Onset of Innate Lung Inflammation by Promoting Mast Cell-Derived IL-6. J Immunol. 2013 ; 190 : 5731-8. https://doi.org/10.4049/jimmunol.1203362
  31. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S. Comparative cytokine gene expression: regulation and release by human mast cells. Immunology. 1998 ; 93(2) : 289-95.
  32. Hosoda M, Yamaya M, Suzuki T, Yamada N, Kamanakam M, Sekizawa K, Butterfield, JH, Watanabe T, Nishimura H, Sasaki H. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J Immunol. 2002 ; 169 : 1482-91. https://doi.org/10.4049/jimmunol.169.3.1482
  33. Bradding P, Roberts JA, Britten KM, Montefort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST. Interleukin -4, -5, -6 and tumour necrosis factor-a in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. J Respir Cell Mol Biol. 1994 ; 10 : 471-80. https://doi.org/10.1165/ajrcmb.10.5.8179909
  34. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or calcium ionophores. Nature. 1989 ; 339 : 64-7. https://doi.org/10.1038/339064a0
  35. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br J Pharmacol. 1989 ; 97 : 898-904. https://doi.org/10.1111/j.1476-5381.1989.tb12030.x
  36. Takubo M, Ueda Y, Yatsuzuka R, Jiang S, Fujii Y, Kamei C. Characteristics of scratching behavior induced by some chemical mediators in hairless mice. J Pharmacol Sci. 2006 ; 100 : 285-8. https://doi.org/10.1254/jphs.FPJ06002X